Atazanavir/Ritonavir Maintenance Therapy

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

May 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Atazanavir

DRUG

Ritonavir

Trial Locations (12)

10011

Weill Cornell Chelsea CRS, New York

15213

University of Pittsburgh CRS, Pittsburgh

27599

Chapel Hill CRS, Chapel Hill

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

45219

Cincinnati CRS, Cincinnati

52242

Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City

75216

Dallas VAMC, Dallas

80045

University of Colorado Hospital CRS, Aurora

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

94304-5350

Stanford AIDS Clinical Trials Unit CRS, Palo Alto

68198-9500

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha

00935

Puerto Rico AIDS Clinical Trials Unit CRS, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00084019 - Atazanavir/Ritonavir Maintenance Therapy | Biotech Hunter | Biotech Hunter